Evaluation of insulin sensitivity by hyperinsulinemic-euglycemic clamps using stable isotope-labeled glucose.
Evaluation of insulin sensitivity by hyperinsulinemic-euglycemic clamps using stable isotope-labeled glucose.
复制标题
使用稳定同位素标记的葡萄糖通过高胰岛素正常血糖钳评估胰岛素敏感性
DOI:
10.1038/s41421-018-0016-3
复制
发表时间:
2018
期刊:
影响因子:
33.5
通讯作者:
Wang Y
中科院分区:
文献类型:
--
作者:
Zhang Y;Xu L;Liu X;Wang Y
Dear Editor, Insulin resistance is a critical factor in the pathogenesis of metabolic diseases such as obesity, nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D) 1. For many years, the hyperinsulinemic-euglycemic clamp has been used as a “gold standard” method to accurately measure insulin action in vivo 2. It is widely used in humans, dogs, rats and mice. During the clamp, glucose kinetics, including the rates of endogenous glucose production and disposal in mice, are conventionally assessed with tracers 3. The radioactive tracer [3-3H] glucose is commonly used because it is sensitive and massless, but it is harmful to our environment, and cannot be used in humans because it is hazardous if introduced into the body 3. Therefore, medical research has turned to stable isotopes as alternative tracers. Although many studies have successfully established the clamp method using stable isotopes in humans, no method has been developed for laboratory mice because of the limitations of mass spectrometry, which requires the infusion of a large dose of stable isotope and a large volume of blood 4–8. In this study, we have successfully devised a sensitive method using [6, 6-2H] glucose as a tracer in mice.[6, 6-2H] glucose is a stable (non-radioactive) naturally occurring isotope with no known harmful effects and similar metabolic effects to normal glucose 5. It can be distinguished from natural isotopomers of glucose (ie, with other isotopic fine structures) using a high resolution mass spectrometer. To establish this method, we tested it in a high-fat diet (HFD)-induced obese mouse model, which is well known and widely used in metabolism research 9–12. Compared to mice fed with a regular diet (RD), HFD-induced obese mice had significantly higher body weight, plasma insulin levels, glucose production measured by pyruvate tolerance test (PTT), glucose intolerance evaluated by glucose tolerance test (GTT) and insulin insensitivity assessed by insulin tolerance test (ITT)(Fig. 1 a–e). All the results indicate that glucose production and insulin resistance were dramatically increased in HFD-fed mice compared to RD-fed animals. To evaluate insulin action and glucose metabolism in vivo, we performed hyperinsulinemic-euglycemic clamp studies using [6, 6-2H] glucose as a tracer (Fig. 1 f, g). A bolus of [6, 6-2H] glucose (600 μg kg− 1) was administered via catheter followed by continuous infusion of [6, 6-2H] glucose at the rate of 30 μg kg− 1 min− 1 for 90 min to maintain steady-state conditions. During the clamp, we monitored the blood glucose levels, plasma insulin levels and glucose infusion rate (GIR)(Fig. 1 h, i, Supplementary Figure S1a). At the steady state, GIR in HFD-fed mice is 12.17±1.09 mg kg− 1 min− 1, which is much lower than that in RD-fed mice (22.10±1.23 mg kg− 1 min− 1), indicating that insulin sensitivity is decreased in HFD-fed mice (Fig. 1 i). In our experiments, levels of glucose and [6, 6-2H] glucose were simultaneously measured using mass spectrometer. To distinguish [6, 6-2H] glucose from natural isotopomers of glucose (M+ 2), we used a high resolution mass spectrometer (Orbitrap) coupled with an ultra-high performance liquid chromatography (UPLC) system. It was recently reported that the Orbitrap machine has a mass resolution of 100,000, and can therefore resolve isotopic fine structures 13. We performed this assay based on a mass resolution of 140,000, which enables us to differentiate oxygen-18 (18O), 13C and 2H isotopes of© The Author (s) 2018
登录
查看更多内容
影响因子:
3.3
作者:
Friedlander, AL;Casazza, GA;Brooks, GA
通讯作者:
Brooks, GA
影响因子:
64.5
作者:
Perry RJ;Camporez JG;Kursawe R;Titchenell PM;Zhang D;Perry CJ;Jurczak MJ;Abudukadier A;Han MS;Zhang XM;Ruan HB;Yang X;Caprio S;Kaech SM;Sul HS;Birnbaum MJ;Davis RJ;Cline GW;Petersen KF;Shulman GI
通讯作者:
Shulman GI
DOI:
10.1097/qai.0b013e3181b03214
发表时间:
2009-10-01
期刊:
Journal of acquired immune deficiency syndromes (1999)
影响因子:
--
作者:
Lee GA;Schwarz JM;Patzek S;Kim S;Dyachenko A;Wen M;Mulligan K;Schambelan M;Grunfeld C
通讯作者:
Grunfeld C
影响因子:
--
作者:
Lutz, Thomas A;Woods, Stephen C
通讯作者:
Woods, Stephen C
影响因子:
64.5
作者:
Samuel VT;Shulman GI
通讯作者:
Shulman GI